Potential for EPR oximetry to guide treatment planning for tumors

Advances in Experimental Medicine and Biology

Volumn 411, Issue , 1997, Pages 233-242

  O'Hara, Julia A ^a   Goda, Fuminori ^a   Dunn, Jeffrey F ^a   Swartz, Harold M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER RADIOTHERAPY; ELECTRON SPIN RESONANCE; HYPOXIA; MOUSE; NONHUMAN; OXIMETRY; PRIORITY JOURNAL; RADIOSENSITIVITY; SOLID TUMOR; TREATMENT FAILURE; TREATMENT PLANNING;

ANIMALIA;

EID: 0030816633     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5865-1_28     Document Type: Article

References (49)

1. R. A. Gatenby, L. R. Coia, M. P. Richter, H. Katz, P. J. Moldofsky, P. Engstrom, D. Q. Brown, R. Brookland and G. J. Broder, Oxygen tension in human tumors: In vivo mapping using CT-guided probes. Radiology. 156, 211-214 (1985).
2. 2tension measurements. Cancer Research. 51, 6098-6102 (1991).
3. P. Okunieff, M. Hoeckel, E. P. Dunphy, K. Schlenger, C. Knoop and P. Vaupel, Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 26, (4), 631-6 (1993).
4. 2, predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 26, (1), 45-50 (1993).
5. E. Lartigau, A. M. Le Ridant, P. Lambin, P. Weeger, L. Martin, R. Sigal, A. Lusinchi, B. Luboinski, F. Eschwege and M. Guichard, Oxygenation of head and neck tumors. Cancer. 71, (7), 2319-25 (1993).
6. R. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia and P. J. Broder, Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 14, 831-838 (1987).
7. P. W. Vaupel, Oxygenation of solid tumors. In Drug Resistance in Oncology (B. A. Teicher, Ed.), pp. 53-86. Marcel Dekker, New York, 1993.
8. H. B. Stone, J. M. Brown, T. L. Phillips and R. M. Sutherland, Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res. 136, (3), 422-34 (1993).
9. J. A. O'Hara, F. Goda, K. J. Liu, G. A. Bacic, P. J. Hoopes and H. M. Swartz, Oxygenation in a murine tumor following radiation: an in vivo electron paramagnetic resonance oximetry study. Radiat Res. 144, (2), 222-229 (1995).
10. F. Goda, J. A. O'Hara, E. S. Rhodes, K. J. Liu, J. F. Dunn, G. Bacic and H. M. Swartz, Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation. Cancer Res. 55, (1 Jun), 2249-2252 (1995).
11. E. J. Hall, Radiobiology for the Radiologist. In Ed.), pp. 143. JB Lippincott, Philadelphia, 1988.
12. L. M. Van Putten and R. F. Kallman, Oxygenation status of a transplantable tumor during fractionated radiation therapy. JNCI. 140, (3), 441-451 (1968).
13. J. E. Moulder and S. Rockwell, Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int J Radiat Oncol Biol Phys. 10, 695-712 (1984).
14. M. R. Horsman, A. A. Khalil, D. W. Siemann, C. Grau, S. A. Hill, E. M. Lynch, D. J. Chaplin and J. Overgaard, Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation, int J Radiat Oncol Biol Phys. 29, (3), 439-42 (1994).
15. K. Sasai and J. M. Brown, Discrepancies between measured changes of radiobiological hypoxic fraction and oxygen tension monitoring using two assay systems. Int J Radiat Oncol Biol Phys. 30, (2), 355-61 (1994).
16. R. K. Jain, Physiological resistance to the treatment of solid tumors. In Drug Resistance in Oncology (B. A. Teicher, Ed.), pp. 87-105. Marcel Dekker, New York, 1993.
17. J. E. Moulder and S. Rockwell, Tumor hypoxia: its impact on cancer therapy. Cancer and metastasis reviews. 5, 313-342 (1987).
18. I. J. Stratford, Bioreductive drugs in cancer therapy. Br J Radiat. Suppl, (24), 128-13 (1992).
19. J. M. Brown and M. J. Lemmon, Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation [see comments]. Int J Radiat Oncol Biol Phys. 20, (3), 457-61 (1991).
20. R. E. Durand and N. E. LePard, Modulation of tumor hypoxia by conventional chemotherapeutic agents. Int J Radiat Oncol Biol Phys. 29, (3), 481-486 (1994).
21. M. J. Dorie and R. F. Kallman, Reoxygenation in the RIF-1 tumor after chemotherapy. Int J Radiat Oncol Biol Phys. 24, (2), 295-9 (1992).
22. 2: and pH semi-microelectrodes. Eur J Cancer. 1, 116-22 (1992).
23. L. Milas, N. Hunter, K. A. Mason, C. Milross and L. J. Peters, Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol. 34, (3), 409-12 (1995).
24. B. A. Teicher, N. P. Dupuis, T. Kusumoto, M. Liu, F. Liu, K. Menon, G. N. Schwartz and I. E Frei. Decreased tumor oxygenation after cyclophosphamide, reoxygenation and therapeutic enhancement with a perflubron emulsion/carbogen breathing. Int J Oncol. 3, 197-203 (1993).
25. M. Busse and P. W. Vaupel, The role of tumor volume in 'reoxygenation' upon cyclophosphamide treatment. Acta Oncologica. 34, (3), 405-408 (1995).
26. T. L. Phillips, Terminology for chemoradiation effects. In Chemoradiation: An Integrated Approach to Cancer Treatment (M. J. John, Ed.), pp. 11-17. Lea & Febiger, Philadelphia, 1993.
27. W. B. Looney and H. A. Hopkins, Rationale for different chemotherapeutic and radiation therapy strategies in cancer management. Cancer. 67, (6), 1471-83 (1991).
28. G. G. Steel and M. J. Peckham, Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Int J Radiat Oncol Biol Phys. 5, 85 (1979).
29. G. G. Steel, The combination of radiotherapy and chemotherapy. In The Biological Basis of Radiotherapy (G. G. Steel, G. E. Adams, and M. J. Peckham, Ed.), pp. 239-248. Elsevier, Amsterdam, 1983.
30. 2 in vivo, including human subjects, by electron paramagnetic resonance. In Oxygen Transport to Tissue (e. a. M.C. Hogan, Ed.), pp. 119-128. Plenum Press, New York, 1994.
31. H. M. Swartz, K. J. Liu, F. Goda and T. Walczak, India ink: A potential clinically applicable EPR oximetry probe. Magn Reson Med. 31, (2), 229-232 (1994).
32. W. B. Looney, H. A. Hopkins and M. Tubiana, Experimental and clinical studies alternating chemotherapy and radiotherapy. Cancer Metastasis Rev. 8, (1), 53-79 (1989).
33. B. A. Teicher, S. A. Holden. S. M. Jones, J. P. Eder and T. S. Herman, Influence of scheduling on two-drug combinations of alkylating agents in vivo. Cancer Chemother Pharmacol. 25, (3), 161-6 (1989).
34. R. F. Kallman. D. Rapacchietta and M. S. Zaghloul, Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/ Km mouse model systems. Int J Radiat Oncol Biol Phys. 20, (2), 227-32 (1991).
35. P. G. Braunschweiger, Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Rex. 48, 4206-4210 (1988).
36. A. C. Begg, K. K. Fu, D. C. Shrieve and T. L. Phillips, Combination therapy of a solid murine tumor with cyclophosphamide and radiation: The effects of time, dose and assay method. Int J Radiat Oncol Biol Phys. 5, 1433-1439 (1979).
37. P. Twentyman, Timing of Assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Int J Radiat Oncol Biol Phys. 5, 1213-1220 (1979).
38. K. H. Clifton, R. C. Briggs and H. B. Stone, Quantitative radiosensitivity studies of solid carcinomas in vivo: methodology and effect of anoxia. J Natl Cane Inst. 36, 965-974 (1966).
39. 125 in a murine tumor system. Rad Res. 118, 112-130 (1989).
40. E. B. Douple, J. A. O'Hara and E. L. Jones, Paraplatin enhancement of radiation therapy in a murine tumor (MTG-B). In Anticancer Drug Research (K. Lapis S. Eckhardt, Ed.), pp. 71-80. Akademiai Kiado. Budapest, 1987.
41. F. Goda, K. J. Liu, T. Walczak, J. A. O'Hara and H. M. Swartz, In vivo oximetry using EPR and India ink. Magn Reson Meet. 33, (2), 237-245 (1995).
42. D. Hand and C. C. Taylor, Multivariate Analysis of Variance anil Repealed Measures, ed. Chapman and Hall, New York, 1987.
43. S. L. Zeger and K. Y. Liang, Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42, 121-130 (1986).
44. M. J. Dorie and R. F. Kallman, Reoxygenation of the RIF-1 tumor after fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 12, 1853-1859 (1986).
45. J. Neter, W. Wasserman and M. H. Kutner, Applied Linear Statistical Models. 2nd ed. RD Irwin Inc. Homewood, IL, 1985.
46. 2 changes in RIF-1 tumors after combined therapy with cyclophosphamide and radiation. Br J Cane. Submitted, (1995).
47. M. R. Horsman, C. Grau and J. Overgaard, Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia. Acta Oncol. 34, (3), 325-8 (1995).
48. W. B. Looney and H.A. Hopkins, Experimental and clinical rationale for alternating chemotherapy and radiotherapy in human cancer management. In Chemoradiation: An Integrated Approach to Cancer Management (M. J. John, Ed.), pp. 27-51. Lea & Febiger, Philadelphia, 1993.
49. P. R. Twentyman, R. F. Kallman and J. M. Brown, The effect of time between x-irradiation and chemotherapy on the growth of three solid mouse tumors. II. Cyclophosphamide. Int J Radiat Oncol Biol Phys. 5, 1425-1427 (1979).